This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration. This website is for informational and educational purposes only. Please do not self-medicate; contact a medical professional for advice before administration.

Erythromycin

PubChem CID: 12560

Connections displayed (default: 10).
Loading graph...

ℹ️ Click here to know more about the properties
Compound Synonyms erythromycin, 114-07-8, Erythromycin A, E-Mycin, Abomacetin, Erythromycinum, Emgel, Erymax, Ilotycin, Eritromicina, Erythromycine, Robimycin, Torlamicina, Eryderm, Erythro-Statin, Erythrocin, Erythromycin base, E-Glades, Ery-Tab, Erycette, Pantomicina, Erygel, Sansac, E-Base, Erythra-Derm, ERYC, Dumotrycin, Mephamycin, Ermycin, Eryacne, Stiemycin, Aknin, Erycen, Wemid, R-P Mycin, Eryc Sprinkles, Theramycin Z, Akne-Mycin, E-Solve 2, Ak-Mycin, Erythromast 36, T-Stat, Erytrociclin, Acneryne, Endoeritrin, Eritomicina, Eryacnen, Erydermer, Eryhexal, Erythroderm, Iloticina, Latotryd, Lederpax, Oftamolets, Pantoderm, Pantodrin, Pharyngocin, Primacine, Proterytrin, Stiemicyn, Tiprocin, Acnesol, Derimer, Deripil, Emuvin, Emycin, Erecin, Erisone, Erymed, Erysafe, Erytab, Erytop, Inderm, Mercina, Romycin, AustriaS, Eros, C-Solve-2, Ery-maxin, Erythro-Teva, Sans-acne, Erimycin-T, Ery-Diolan, Inderm Gel, Del-Mycin, Udima Ery Gel, Aknederm Ery Gel, Abboticin, Emu-Ve, Akne Cordes Losung, Eryc 125, Ilotycin T.S., Skid Gel E, E-Mycin (base), Emu-V, Ery-B, Ery-Tab (base), E-Base (base), ERYC (base), erythromycin-A, A/T/S, Erythrogran, Erythroguent, Erythromid, Propiocine, Dotycin, Erycinum, Ilocaps, PCE Dispertab (base), Erycin, Kesso-Mycin, Eryc-125, Eryc-250, Taimoxin-F, ERYTHROMYCIN STEARATE, erythro, Oftalmolosa Cusi Eritromicina, Eritrocina, Staticin, Retcin, erthromycin, MFCD00084654, Sentry AQ mardel maracyn, Eritromicina [INN-Spanish], Erythromycine [INN-French], Erythromycinum [INN-Latin], Benzamycin, CCRIS 9078, DTXSID4022991, UNII-63937KV33D, CHEBI:42355, HSDB 3074, EM-A, EINECS 204-040-1, NSC 55929, NSC-55929, PCE (ERYTHROMYCIN), CHEMBL532, 63937KV33D, AI3-50138, DTXCID102991, J01FA01, EC 204-040-1, Erythromycin [USP:INN:BAN:JAN], NSC55929, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, ERY, BENZAMYCIN COMPONENT ERYTHROMYCIN, Erythromycin C-13, Aknemycin, Eritromicina (INN-Spanish), Erythromycine (INN-French), Erythromycinum (INN-Latin), 8HPH7ND0LN, ERYTHROMYCIN (MART.), ERYTHROMYCIN [MART.], (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione, Ilosone (estolate), ERYTHROMYCIN (USP-RS), ERYTHROMYCIN [USP-RS], N-Methylerythromycin A, ERYTHROMYCIN (EP MONOGRAPH), Erythromycin (USP:INN:BAN:JAN), ERYTHROMYCIN [EP MONOGRAPH], ERYTHROMYCIN (USP MONOGRAPH), ERYTHROMYCIN [USP MONOGRAPH], 643-22-1, 7704-67-8, Erythromycin, labeled with carbon-13, Staticin (TN), Akne-mycin (TN), Erygel (TN), Eryc (TN), T-stat (TN), Pce (TN), SR-05000001618, Erythromycin & VRC3375, Spotex, ErythromycinBase, 82343-12-2, Gallimycin-36, NCGC00094670-01, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, CAS-114-07-8, Prestwick_205, 215031-94-0, Spectrum_000115, Spectrum_000659, ErythromycinBase Filmtab, Erythro-100 Injection, API E.M. Erythromycin, Erythromycin Base Filmtab, Prestwick3_000151, Spectrum2_000759, Spectrum2_001263, Spectrum4_000538, Spectrum5_001596, UNII-8HPH7ND0LN, ERYTHROMYCIN [MI], E0751, Erythromycin A, B + C, Erythro-36, Erythro-Dry, ERYTHROMYCIN [INN], ERYTHROMYCIN [JAN], ERYTHROMYCIN [HSDB], SCHEMBL2601, API E.M ERYTHROMYCIN, ERYTHROMYCIN [VANDF], BSPBio_000282, BSPBio_002480, KBioGR_001175, KBioSS_000555, KBioSS_001139, MLS001066618, BIDD:GT0017, DivK1c_000294, DivK1c_000397, DivK1c_000702, ERYTHROMYCIN [WHO-DD], ERYTHROMYCIN [WHO-IP], SPECTRUM1500280, SPBio_000778, SPBio_001226, E-Base, E-Mycin, Erytromycin A, BPBio1_000312, GTPL1456, CHEBI:48923, Erythromycin (JP18/USP/INN), HMS500O16, KBio1_000294, KBio1_000397, KBio1_000702, KBio2_000555, KBio2_001139, KBio2_003123, KBio2_003707, KBio2_005691, KBio2_006275, ERYTHROMYCIN [GREEN BOOK], MSK7801, NINDS_000294, NINDS_000397, NINDS_000702, ERYTHROMYCIN [ORANGE BOOK], HMS1920M04, HMS2091D05, HMS2095O04, HMS3712O04, Pharmakon1600-01500280, HY-B0220, RKL10096, Tox21_111311, Tox21_111869, Tox21_300515, BDBM50344942, CCG-38992, LMPK04000006, NSC756759, ERYTHROMYCINUM [WHO-IP LATIN], Gallimycin Injection, Gallimycin-100, AKOS015895249, 1ST7801, AE22796, DB00199, NSC-756759, IDI1_000294, IDI1_000397, IDI1_000702, SMP1_000119, NCGC00179619-01, NCGC00179619-02, NCGC00179619-03, NCGC00254234-01, AC-12744, AC-12901, SMR000544946, ERYTHROMYCIN COMPONENT OF BENZAMYCIN, Erythromycin, potency: >=850 mug per mg, Erythromycin, tested according to Ph.Eur., SBI-0051368.P003, Erythromycin, N-demethyl-N-(methyl-11C)-, Erythromycin 1000 microg/mL in Acetonitrile, NS00000203, Erythromycin, meets USP testing specifications, C01912, D00140, AB00051981_09, AB00051981_10, Erythromycin, Biotechnology Performance Certified, Erythromycin estolate impurity, free erythromycin-, Q213511, SR-01000799155, Erythromycin, BioReagent, suitable for cell culture, SR-01000799155-2, SR-05000001618-1, SR-05000001618-2, BRD-K63550407-001-12-7, BRD-K63550407-001-13-5, BRD-K63550407-028-03-9, BRD-K63550407-028-04-7, Z2587996953, Erythromycin A, European Pharmacopoeia (EP) Reference Standard, Erythromycin, United States Pharmacopeia (USP) Reference Standard, ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN [EP IMPURITY], ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN- [USP IMPURITY], Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard, Erythromycin, Pharmaceutical Secondary Standard, Certified Reference Material, (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name), 204-040-1, 7540-22-9
Topological Polar Surface Area 194.0
Hydrogen Bond Donor Count 5.0
Heavy Atom Count 51.0
Description It is used in foods as stabiliser, surface-finishing agent and thickener. Derived from collagen
Isotope Atom Count 0.0
Molecular Complexity 1180.0
Database Name cmaup_ingredients;fooddb_chem_all;npass_chem_all;pubchem
Defined Atom Stereocenter Count 18.0
Uniprot Id n.a., O43193, P02743, P08684, P08183, P21447, P06795, Q12809, Q16850, Q92887, O15245, A5A4K8, P00811, P10520, P02768, P33527, P46721, P24666, P17405, O75496, O94956, Q9NPD5, Q9Y6L6, Q96FL8, Q9NUW8, O95398, P53350, P05177, P20813, P10632, P51589, P11712, P33261, P10635, P11797, O95342, O15438, O15439, Q16678, Q16762, Q7BGE6, P61604, P0A6F5, Q06278, P0DTD1
Iupac Name (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
Prediction Hob 1.0
Target Id NPT5301, NPT109, NPT668, NPT98, NPT1604, NPT2742
Xlogp 2.7
Molecular Formula C37H67NO13
Prediction Swissadme 0.0
Inchi Key ULGZDMOVFRHVEP-RWJQBGPGSA-N
Fcsp3 0.945945945945946
Logs -3.067
Rotatable Bond Count 7.0
Logd 0.864
Synonyms Emagel, Gelafusal, Gelatin type I, Gelatine bloom 250, Gelfoam, Nikkol CCP4, Pharmagel A, Puragel, Rousselot 3046, Spongiofort
Compound Name Erythromycin
Prediction Hob Swissadme 0.0
Exact Mass 733.461
Formal Charge 0.0
Monoisotopic Mass 733.461
Hydrogen Bond Acceptor Count 14.0
Molecular Weight 733.9
Covalent Unit Count 1.0
Total Atom Stereocenter Count 18.0
Total Bond Stereocenter Count 0.0
Esol -5.856209400000003
Inchi InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
Smiles CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
Nring 3.0
Defined Bond Stereocenter Count 0.0

  • 1. Outgoing r'ship FOUND_IN to/from Piper Nigrum (Plant) Rel Props:Source_db:cmaup_ingredients;npass_chem_all
Back to Browse   Back to Home